Kartik Bhatia | Medicine and Dentistry | Research Excellence Award

Published on by World Top Scientists

Assoc. Prof. Dr. Kartik Bhatia | Medicine and Dentistry | Research Excellence Award 

Clinical Associate Professor | University of Sydney | Australia

Associate Professor Dr. Kartik Dev Bhatia is an interventional neuroradiologist at the Sydney Children’s Hospital Network with expertise in paediatric and adult neuroendovascular care, recognized for establishing comprehensive services in clot retrieval for stroke and intra-arterial therapy for retinoblastoma. He holds a PhD and advanced clinical qualifications including subspecialty recognition in interventional neuroradiology, fellowship of the Royal Australian and New Zealand College of Radiologists, and dual medical and surgical degrees, underpinning a strong academic and clinical foundation. His professional experience spans leadership of multidisciplinary cerebrovascular programs, major fellowships across leading Australian and international centres, and service as a staff specialist and consultant interventional neuroradiologist across multiple tertiary hospitals. Dr. Bhatia’s research focuses on paediatric neurointervention, stroke, vascular malformations, and innovative endovascular therapies, with influential publications in high-impact journals and contributions to key international registries. He has authored multiple book chapters and serves as a reviewer for prominent journals in neuroradiology, neurology, and stroke medicine, reflecting his standing in the academic community. His work has advanced understanding of paediatric cerebrovascular disease, liquid biopsy applications in vascular malformations, and endovascular treatment paradigms. A recipient of distinctions including a Research Excellence Award, he also contributes through editorial activities, scholarly mentorship, and active membership in multidisciplinary and professional bodies. Dr. Bhatia’s blend of clinical innovation, academic leadership, and sustained research impact positions him as an outstanding candidate for recognition.

Citation Metrics (Google Scholar)

1500
1000
500
0

1409
Citations

22
h-index

30
i10-index


View Google Scholar Profile

Top Publications

Francesco De Francesco | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Francesco De Francesco | Medicine and Dentistry | Best Researcher Award

Medical Surgeon | Azienda Ospedaliera Universitaria delle Marche | Italy

Dr. Francesco De Francesco is an accomplished clinician-scientist specializing in plastic, reconstructive, and regenerative surgery, with a strong academic background in stem cell biology and tissue engineering. His career reflects a balance of clinical expertise, laboratory research, and teaching, enabling him to translate scientific discoveries into therapeutic innovations. His work has focused extensively on adipose-derived stem cells, extracellular vesicles, and their applications in regenerative medicine, particularly in joint and soft tissue repair. Alongside his research, he has played an important role as a medical executive, advancing clinical practices in reconstructive and hand surgery. He has also contributed to academic training, fostering knowledge transfer and supporting the next generation of medical professionals. Recognized with national scientific qualifications and specialization, his profile reflects leadership, dedication, and significant impact in his field. His measurable research influence is demonstrated through Scopus with 3,218 citations, 122 documents, and an h-index of 30.

Profiles: Scopus | Google Scholar | ORCID

Featured Publications

1.  V. Tirino, V. Desiderio, F. Paino, A. De Rosa, F. Papaccio, M. La Noce, and F. De Francesco, “Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization,” The FASEB Journal, vol. 27, no. 1, pp. 13–24, 2013.

2. V. Tirino, V. Desiderio, R. d’Aquino, F. De Francesco, G. Pirozzi, U. Galderisi, and F. Papaccio, “Detection and characterization of CD133+ cancer stem cells in human solid tumours,” PLoS One, vol. 3, no. 10, p. e3469, 2008.

3. A. Graziano, R. d’Aquino, M. G. C. D. Angelis, F. De Francesco, A. Giordano, and G. Papaccio, “Scaffold’s surface geometry significantly affects human stem cell bone tissue engineering,” Journal of Cellular Physiology, vol. 214, no. 1, pp. 166–172, 2008.

4. F. De Francesco, G. Ricci, F. D’Andrea, G. F. Nicoletti, and G. A. Ferraro, “Human adipose stem cells: from bench to bedside,” Tissue Engineering Part B: Reviews, vol. 21, no. 6, pp. 572–584, 2015.

5. F. De Francesco, V. Tirino, V. Desiderio, G. Ferraro, F. D’Andrea, M. Giuliano, and F. Papaccio, “Human CD34+/CD90+ ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries,” PLoS One, vol. 4, no. 8, p. e6537, 2009.

Geng-Long Hsu | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Geng-Long Hsu | Medicine and Dentistry | Best Researcher Award

Director | Hsu’s Andrology | Taiwan

Prof. Dr. Geng-Long Hsu is a distinguished urologist and microsurgical potency reconstruction specialist with decades of experience in clinical practice, research, and education. He has pioneered innovative surgical techniques and contributed significant anatomical and physiological insights in male reproductive medicine. His leadership in multiple research centers and academic institutions has fostered a strong culture of mentorship and collaboration. Dr. Hsu is recognized internationally through memberships in professional societies and numerous awards for both basic and clinical research, highlighting the global impact of his work. His research demonstrates a consistent focus on advancing urological science, integrating clinical expertise with experimental innovation. Through his contributions, he has influenced treatment protocols and surgical outcomes in male reproductive health. His measurable research impact is reflected in Scopus, with 1,521 citations across 68 documents and an h-index of 22, underscoring the significance and reach of his scholarly work.

Profiles: Scopus | ORCID

Featured Publications

1. G.-L. Hsu, “Combining erection restoration and factual penile enhancement based on revolutionary penile fibro-vascular assembly,” Archivos Espanoles De Urologia, 2025.

2. G.-L. Hsu, “A detailed analysis of the penile fibro-vascular assembly,” Journal of Sexual Medicine, 2025.

3. G.-L. Hsu, “Coil embolization is not justified for treating patients with veno-occlusive dysfunction: Case series and narrative literature review,” Life, 2024.

4. G.-L. Hsu, “Emergent penile venous stripping for treating adolescent impotence,” Life, 2024.

5. G.-L. Hsu, “A case report of right cardiac ventricle perforation by uncontrolled embolization coil inserted for treating penile veno-occlusive dysfunction,” Urology Case Reports, 2022.

Laura Garriga-Grimau | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Laura Garriga-Grimau | Medicine and Dentistry | Best Researcher Award

Physician at Hospital Universitari Vall d’Hebron, Spain

Dr. Laura Garriga-Grimau is a dedicated pediatric pulmonologist based at Vall d’Hebron University Hospital in Barcelona, Spain. She specializes in bronchiectasis, cystic fibrosis, and other chronic pediatric lung conditions. Her work bridges clinical practice, academic research, and teaching. She is actively involved in multiple international research collaborations, including the European Respiratory Society (ERS) and the Child-BEAR-Net Registry. A strong advocate for improving respiratory care in children, Dr. Garriga-Grimau has authored numerous peer-reviewed publications and contributed to global studies shaping pediatric lung health guidelines. Her academic and clinical background is enriched by international clinical training in Australia and active teaching roles at the Autonomous University of Barcelona. Known for her collaborative leadership and deep scientific insight, she continues to contribute to innovation in pediatric respiratory medicine while mentoring future healthcare professionals. Her work is both evidence-driven and patient-centered, earning her a growing reputation in European and global pediatric research communities.

🔹 Professional Profile 

Scopus Profile
ORCID Profile 

🏆Strengths for the Award

Dr. Laura Garriga-Grimau has demonstrated a strong commitment to advancing pediatric respiratory medicine through a blend of clinical excellence, academic research, and international collaboration. Her specialization in bronchiectasis and cystic fibrosis has positioned her as a key contributor in areas that are often underrepresented in pediatric research. She currently holds leadership roles in prominent research initiatives, such as Chair of the ERS Task Force on Transitioning Adolescents with Bronchiectasis, and Deputy Co-Chair of the Child-BEAR-Net Registry, reflecting the recognition she commands within global respiratory research communities. These roles not only highlight her scientific insight but also her ability to coordinate multinational teams and influence clinical policy development.

Her publication record is both prolific and impactful, including research in The Lancet Respiratory Medicine, New England Journal of Medicine, and other peer-reviewed international journals. Dr. Garriga-Grimau has contributed to high-quality, multi-center studies and registries that address real-world challenges in diagnosis, treatment, and care models for pediatric lung diseases. Notably, her involvement in the SHIP-CT trial and the Spanish Pediatric Bronchiectasis Registry demonstrates her ability to participate in and lead complex clinical research initiatives with both academic and translational value. Her research outputs are data-driven, well-cited, and directly relevant to improving health outcomes in children globally.

In addition to her research achievements, Dr. Garriga-Grimau has actively bridged the gap between academia and clinical practice. She contributes as a faculty member in the Pediatric Pulmonology Master’s program at the Autonomous University of Barcelona and has been involved in mentoring and training future clinicians and researchers. Her international clinical exposure, including a bronchiectasis fellowship in Australia, enhances the global relevance and cultural sensitivity of her work. This combination of academic productivity, clinical innovation, and leadership in international research networks makes her a well-rounded and highly deserving candidate for the Best Researcher Award.

🎓Education

Dr. Laura Garriga-Grimau completed her medical education and pediatric residency through the Spanish MIR system at the University of Barcelona, one of Spain’s leading academic medical centers. Following her pediatric training, she pursued specialized academic advancement through a Master’s degree in Pediatric Pulmonology from the Autonomous University of Barcelona (UAB), where she later became a faculty member. Her passion for research and respiratory medicine led her to complete a PhD focused on cystic fibrosis at Vall d’Hebron University Hospital, contributing significant findings to the field. In addition to her formal education, Dr. Garriga-Grimau enriched her academic and clinical knowledge with a training fellowship in bronchiectasis at the Queensland Children’s Hospital in Australia. Her continuous pursuit of learning, from clinical practice to translational research, has equipped her with a strong foundation in evidence-based medicine and multidisciplinary collaboration, shaping her into a leader in pediatric respiratory care both in Spain and internationally.

💼 Experience

Dr. Laura Garriga-Grimau has built an extensive and dynamic professional career in pediatric pulmonology, anchored at Vall d’Hebron University Hospital. She serves as a consultant in the Pediatric Pulmonology Department, where she treats complex respiratory conditions, including cystic fibrosis and bronchiectasis. Her clinical experience is complemented by her academic involvement as a lecturer in the Pediatric Pulmonology Master’s program at the Autonomous University of Barcelona. She completed international clinical training in Australia, focusing on bronchiectasis, and collaborates with research networks such as the ERS, ERN-Lung, and Child-BEAR-Net. Her career integrates hands-on patient care with data-driven research, highlighting her ability to translate science into practice. In leadership roles such as Chair of the ERS Task Force on adolescent bronchiectasis transition and Deputy Co-Chair of Child-BEAR-Net, she coordinates multinational teams and projects. Her balanced experience across clinical, research, and educational domains establishes her as a well-rounded and forward-thinking physician-scientist.

🏆 Awards and Honors

While specific individual awards are not listed in her profile, Dr. Laura Garriga-Grimau’s numerous prestigious roles and peer-reviewed publications serve as strong indicators of her academic and professional recognition. She has earned notable leadership positions in internationally recognized research bodies such as the European Respiratory Society (ERS) and the Child-BEAR-Net network, which are typically awarded based on merit, contribution, and peer endorsement. She is a key author and collaborator in top-tier journals including The Lancet Respiratory Medicine and The New England Journal of Medicine—an honor in itself that reflects a high level of expertise and scientific impact. Her inclusion in global studies and research registries, as well as her involvement in shaping clinical guidelines, affirms her reputation in the field of pediatric pulmonology. Furthermore, her appointment as faculty at a major academic institution and her PhD achievements represent high academic recognition within both national and international medical communities.

🔬Research Focus on Medicine and Dentistry

Dr. Garriga-Grimau’s research centers on pediatric bronchiectasis, cystic fibrosis, and related respiratory disorders, with an emphasis on improving diagnostics, treatment protocols, and health equity in chronic pediatric lung care. She is actively involved in several major international studies and registries, including the Child-BEAR-Net Registry and SHIP-CT trial. Her research evaluates multicountry clinical variations, healthcare transitions from adolescence to adulthood, and therapy optimization for children with chronic respiratory disease. She collaborates on translational studies that influence clinical guidelines and promote standardized care across different healthcare systems. Her work particularly emphasizes underserved populations, including Indigenous communities, reflecting her commitment to inclusive, global health research. By integrating clinical experience with robust epidemiological and translational approaches, Dr. Garriga-Grimau’s research not only advances scientific understanding but also directly enhances patient outcomes. She contributes to major publications and plays key roles in shaping pediatric pulmonology’s research priorities at the European and global level.

📚 Publications Top Notes

  • First results from the international paediatric bronchiectasis registry (Child‑BEAR‑Net Registry) describing multicountry variations in childhood bronchiectasis and its management: a multicentre, cross‑sectional study

    • Authors: Laura Garriga‑Grimau; Ahmad Kantar; Keith Grimwood; Charl Verwey; Refiloe Masekela; Diane Gray; Ameena Goga; Bulent Karadag; Ela Erdem Eralp; Yasemin Gokdemir; et al.

    • Year: 2025

    • Citations: 1 (as per Scopus/ResearchGate)

  • Guiding practice principles for clinicians who work with Indigenous people

    • Authors: André Schultz; Anne B. Chang; Donna M. Mason; Julie M. Marchant; Lesley A. Versteegh; Maree Toombs; Laura Garriga‑Grimau; CRE Extended Group

    • Year: 2025

  • Bronchiectasis in pediatrics

    • Authors: Laura Garriga‑Grimau; Eva Polverino; Antonio Moreno‑Galdó

    • Year: 2025

  • Implementation of the Spanish Paediatric Bronchiectasis Registry (Child‑BEAR‑es Registry)

    • Authors: Laura Garriga‑Grimau; Verónica Sanz‑Santiago; Antonio Moreno‑Galdó

    • Year: 2024

  • Improving the Diagnosis and Treatment of Paediatric Bronchiectasis Through Research and Translation

    • Authors: Anne B. Chang; Shyamali C. Dharmage; Julie M. Marchant; Gabrielle B. McCallum; Peter S. Morris; Andre Schultz; Maree Toombs; Danielle F. Wurzel; Stephanie T. Yerkovich; Keith Grimwood; Laura Garriga‑Grimau; CRE extended group

    • Year: 2024

  • Asma (book chapter)

    • Author: Laura Garriga‑Grimau

    • Year: 2022

  • Pneumònia per Streptococcus pyogenes a l’edat pediàtrica

    • Author: Laura Garriga‑Grimau

    • Year: 2022

  • The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP‑CT)

    • Authors: Harm A.W.M. Tiddens; Yuxin Chen; Eleni‑Rosalina Andrinopoulou; et al., including Laura Garriga‑Grimau

    • Year: 2022

  • Triple Therapy for Cystic Fibrosis Phe508del‑Gating and ‑Residual Function Genotypes

    • Authors: Peter J. Barry; Marcus A. Mall; Antonio Álvarez; et al., including Laura Garriga‑Grimau

    • Year: 2021

  • How abnormal is the normal? Clinical characteristics of CF patients with normal FEV₁

    • Authors: Malena Cohen‑Cymberknoh; Elad Ben Meir; Silvia Gartner; et al., including Laura Garriga‑Grimau

    • Year: 2021

  • Earlier clinical case reports (2012–2015)

    • Authors: Laura Garriga‑Grimau et al.

    • Years: 2012–2015

📌 Conclusion

Dr. Laura Garriga-Grimau exemplifies the rare combination of clinical expertise, academic leadership, and collaborative spirit essential for advancing global pediatric pulmonology. Her commitment to research excellence, her leadership in multinational registries and task forces, and her drive to improve outcomes for children with chronic respiratory diseases mark her as an innovator in the field. Whether through her patient care, her mentorship of future specialists, or her groundbreaking studies in bronchiectasis and cystic fibrosis, Dr. Garriga-Grimau continues to push the boundaries of pediatric respiratory medicine. Her contributions resonate not only within academic journals but also in real-world clinical settings across borders. As she builds on her already distinguished career, she remains a key force in shaping the future of respiratory healthcare for children worldwide. Dr. Garriga-Grimau is undoubtedly a deserving candidate for any accolade recognizing research excellence, innovation, and global impact in medicine.

Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Doctor at Medical University, Varna, Bulgaria

Dr. Yoana Dyankova Dyankova is a dedicated pediatrician and clinical researcher specializing in pediatric gastroenterology, hepatology, and nutrition. She holds a PhD in Pediatrics from the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, where she also serves in the Pediatric Intensive Care Unit at St. Marina University Hospital. Her research focuses primarily on celiac disease in children, particularly its impact on bone health, as demonstrated in her dissertation and multiple peer-reviewed publications, including a recent article in Nutrients (2025). Dr. Dyankova is an active member of national pediatric and gastroenterology associations and contributes to both clinical care and academic development. Fluent in English and German, she engages with the international scientific community and remains committed to translating research into improved patient outcomes. With her growing publication record, clinical integration, and academic rigor, she stands out as a promising young researcher in the field of pediatric medicine.

Professional Profile 

Google Scholar
ORCID Profile 

Education

Dr. Yoana Dyankova Dyankova began her academic journey at the Vasil Drumev High School of Natural Sciences and Mathematics in Veliko Tarnovo, graduating in 2010. She pursued her medical degree at the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, completing it in 2016. From 2017 to 2022, she specialized in pediatrics, gaining comprehensive clinical training and board certification in the field. In 2018, she enrolled in a PhD program in Pediatrics at the same university, where she focused her research on celiac disease and its effects on pediatric bone health. She successfully defended her dissertation in 2023. Dr. Dyankova has since continued to develop professionally by pursuing further specialization in pediatric gastroenterology starting in July 2025. Her academic path demonstrates strong commitment, discipline, and a focused interest in improving pediatric healthcare through both clinical practice and rigorous scientific research.

Professional Experience

Dr. Dyankova has cultivated a balanced career combining clinical excellence and academic growth. Since January 2022, she has served as a pediatrician at the Pediatric Intensive Care Unit (PICU) of the First Children’s Clinic, St. Marina University Hospital in Varna. Her role in the PICU places her at the frontline of managing critically ill children, often requiring advanced decision-making and teamwork in high-pressure situations. Prior to this, she completed a five-year pediatric residency, gaining hands-on experience in general pediatrics. Her transition into the subspecialty of pediatric gastroenterology as of July 2025 marks a strategic shift aligned with her research interests. Parallel to her clinical duties, Dr. Dyankova was engaged in doctoral studies for five years, conducting original research and contributing to academic publications. Her dual role as both a clinician and researcher enhances her ability to apply scientific findings directly to patient care, making her a valuable asset in modern pediatric medicine.

Research Interest

Dr. Dyankova’s primary research interests lie at the intersection of pediatric gastroenterology, hepatology, and nutrition, with a concentrated focus on celiac disease (CD). Her doctoral thesis explored bone health in children with CD, addressing the metabolic and developmental complications arising from malabsorption and chronic inflammation. Beyond celiac disease, she has expressed research interest in related gastrointestinal disorders such as inflammatory bowel disease (IBD), as well as broader issues within pediatric intensive care. Her work is characterized by clinical relevance and translational value, aiming to bridge the gap between scientific research and bedside care. Publications in both national and international journals reflect her dedication to improving diagnostic and treatment protocols in children with chronic gastrointestinal conditions. Dr. Dyankova continues to build her research portfolio by participating in collaborative studies, focusing on early diagnosis, nutritional interventions, and long-term management outcomes in affected pediatric populations, ensuring a direct impact on clinical practice.

Award and Honor

While specific named awards are not listed in the biography, Dr. Yoana Dyankova Dyankova has received notable academic and professional recognition through her successful completion of a PhD and multiple scientific publications. Her research has been published in reputable journals such as Nutrients, indicating peer validation and relevance of her work. She is an active member of the National Pediatric Association and the community of Pediatric Gastroenterologists in Bulgaria, reflecting her standing in the professional community. These memberships signify not only recognition by peers but also her continued contribution to scientific discussions and advancements in pediatric healthcare. Her role in high-stakes clinical environments like the Pediatric Intensive Care Unit further demonstrates trust in her medical competence and decision-making. With growing academic output and clear specialization in a crucial field, Dr. Dyankova is well-positioned to earn future distinctions and leadership roles in pediatric research and clinical practice at both national and international levels.

Conclusion

Dr. Yoana Dyankova Dyankova exemplifies the qualities of a dedicated clinician-scientist, balancing hands-on pediatric care with high-impact academic research. With a solid foundation in pediatrics and a focused interest in gastroenterology and nutrition, she has steadily advanced her career through both clinical excellence and scholarly contribution. Her doctoral work on bone health in children with celiac disease highlights her ability to address complex, real-world health challenges through evidence-based research. Now working in a pediatric intensive care setting and continuing her subspecialty training, Dr. Dyankova is expanding her expertise and influence in critical areas of child health. Her publications, professional affiliations, and academic achievements underscore a deep commitment to the advancement of pediatric medicine. While still early in her career, her trajectory suggests strong potential for leadership in research and healthcare. She is a promising candidate for recognition such as the Best Researcher Award and is well-poised for continued professional impact.

Publications Top Notes

  1. Title: Presentation of Childhood Newly-Diagnosed Diabetes During the COVID-19 Pandemic – Is There a Change?

    • Authors: Y. Bazdarska, V. Iotova, T. Karamfilova, Y. Dyankova, T. Stefanova, …

    • Journal: Diabetes Technology & Therapeutics, Vol. 23, A202

    • Year: 2021

  1. Title: Delayed Bone Age and Osteoprotegerin Levels in Pediatric Celiac Disease: A Three-Year Case–Control Study

    • Authors: R. Pancheva, Y. Dyankova, N. Rasheva, K. Koleva, V. Iotova, M. Dzhogova, M. Fiore, M. Georgieva

    • Journal: Nutrients, Vol. 17 (14), Article 2295

    • Year: 2025

  1. Title: Macrophage Activation Syndrome After COVID-19 Infection in a Patient with Systemic Juvenile Idiopathic Arthritis

    • Authors: M. Boyadzhiev, B. Varbanova, M. Belcheva, P. Shivachev, D. Krumova, Y. Dyankova, …

    • Journal: Scripta Scientifica Medica, Vol. 55(1), pp. 27–31

    • Year: 2023

  1. Title: Bone Health in Children with Celiac Disease (PhD Dissertation)

    • Author: Y. Dyankova

    • Database: PQDT-Global (ProQuest Dissertations)

    • Year: 2022

  1. Title: New Developments in the Diagnostics of Celiac Disease in Children

    • Authors: Y. Dyankova, M. Georgieva, N. Rasheva, K. Koleva

    • Journal: Journal of the Union of Scientists-Varna. Medicine and Ecology Series, Vol. 24(1)

    • Year: 2019

  1. Title: Bacterial Pulmonary Colonization with Pseudomonas aeruginosa in Cystic Fibrosis Patients

    • Authors: M. Nikolova, Y. Dyankova, I. Hristov, M. Georgieva

    • Journal: Izvestia Journal of the Union of Scientists-Varna. Medicine and Ecology Series

    • Year: 2019

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Professor at IDIVAL, Spain

Professor Javier Crespo is a distinguished physician-scientist and academic leader in the field of digestive and liver diseases. Currently a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL, he has made significant contributions through over 400 original publications, more than 120 clinical trials, and leadership in numerous national and international research projects. With an H-index of 70 and over 30,000 citations, his work has had a profound global impact. He has played a pivotal role in national health strategies, including Spain’s Hepatitis C elimination plan, and served as President of major professional societies such as SEPD. A mentor to numerous doctoral and master’s students, he has also received multiple prestigious awards for his contributions to medicine and research. His leadership at Marqués de Valdecilla University Hospital earned repeated national recognition for excellence in digestive and hepatitis care.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Professor Javier Crespo earned his Degree in Medicine and General Surgery from the University of Cantabria with an Outstanding qualification. He later obtained his Doctorate in Medicine in 1993, receiving the Extraordinary Doctorate Award for academic excellence. His formal education laid a strong foundation for a career marked by clinical rigor and academic depth. In addition to his medical qualifications, he has been accredited as a Professor by ANECA (the Spanish National Agency for Quality Assessment and Accreditation). His academic journey reflects not only excellence in performance but also an enduring commitment to scientific learning and advancement. His scholarly trajectory is rooted in a lifelong dedication to the field of hepatology and digestive pathology, with an early focus on merging basic medical science with clinical research. These formative years have played a crucial role in shaping his influential career in medicine, teaching, and research.

Professional Experience

Professor Crespo has held several prestigious positions throughout his career. He is a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL. He served as Head of the Digestive Service at Marqués de Valdecilla University Hospital from 2010 to 2024. Additionally, he has played strategic roles in healthcare governance, including being a member of Spain’s National Strategic Plan against Hepatitis C since 2015 and coordinator of the AEEH National Liver Health Plan Challenge 2032. His leadership extends to professional societies—he served as President of the Spanish Society of Digestive Pathology (SEPD), President of the National Digestive Commission, and Secretary of the Spanish Association for the Study of the Liver. His professional career reflects a unique blend of clinical excellence, policy leadership, academic mentoring, and research management, making him one of the most respected figures in his specialty.

Research Interest

Professor Crespo’s primary research interests center around digestive and liver diseases, with a particular focus on hepatitis C, liver cirrhosis, and inflammatory bowel diseases. He has led more than 120 clinical trials across Phases I–III and participated in 15 national and 8 international competitive research projects. His translational approach bridges laboratory findings with clinical application, especially in hepatology. Under his leadership, the IDIVAL research group has produced high-impact findings in digestive pathology and liver disease progression. He has authored over 400 original scientific articles, with a strong presence in high-impact journals. His work is cited more than 30,000 times, and he holds an H-index of 70, underscoring his global influence. He is also actively involved in supervising doctoral and postgraduate theses, reflecting his dedication to advancing the next generation of researchers in gastroenterology. His research has contributed significantly to public health, particularly in the management and elimination of hepatitis C.

Award and Honor

Professor Javier Crespo has received numerous national and international awards that recognize both his scientific excellence and public health impact. Among his most prestigious accolades are the Elimination Champions 2023 International Award, granted by the Coalition for Global Hepatitis Elimination, and the International Award at the VI LIFE Forum for HCV Elimination in Lima (2024). Nationally, he has been honored with the Commendation of the Civil Order of Health, the SEPD Gold Medal, and the ACAD Gold Medal. He was also named an Illustrious Torrelaveguense in 2024. Under his leadership, the Digestive Service at Marqués de Valdecilla University Hospital received the Best in Class Award for several consecutive years for excellence in digestive and hepatitis care. His honors reflect not only scientific merit but also his dedication to clinical service and public health leadership, making him one of the most decorated professionals in his field.

Conclusion

In conclusion, Professor Javier Crespo is a highly accomplished and impactful leader in the fields of gastroenterology and hepatology. His career combines outstanding academic achievement, clinical leadership, and translational research excellence. With more than 30,000 citations and an H-index of 70, his scientific contributions have shaped current practices in liver disease treatment and public health strategies. He has held top-level positions in hospitals, universities, research institutes, and national health commissions, evidencing his multifaceted influence. Through his mentorship, he has cultivated a generation of researchers and clinicians, further extending his legacy. His work has not only garnered national and international recognition through prestigious awards but has also led to meaningful improvements in patient care, especially in hepatitis C management. Professor Crespo exemplifies the qualities of a visionary researcher, a compassionate physician, and a dedicated educator—making him exceptionally worthy of recognition such as the Best Researcher Award.

Publications Top Notes

  • Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis

    • Authors: Not listed

    • Year: 2025

    • Citations: 3

  • Letter to the Editor: Optimizing MASLD treatment—A “lead-in phase” before resmetirom

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • Comprehensive Diagnosis of Viral Hepatitis in Spain: Bases for Implementation

    • Authors: Not listed

    • Year: 2025

  • Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    • Authors: ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, …

    • Year: 2023

    • Citations: 4,096

  • Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn’s disease

    • Authors: N Inohara, Y Ogura, A Fontalba, O Gutierrez, F Pons, J Crespo, K Fukase, …

    • Year: 2003

    • Citations: 2,245

  • Modeling NAFLD disease burden in 8 countries (2016–2030)

    • Authors: C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, …

    • Year: 2018

    • Citations: 2,027

  • A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    • Authors: HSA Newsome, PN Buchholtz, K Cusi, M Linder, T Okanoue, V Ratziu, S Sanyal, …

    • Year: 2021

    • Citations: 1,673

  • Obeticholic acid for the treatment of NASH: Phase 3 trial analysis

    • Authors: ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, …

    • Year: 2019

    • Citations: 1,286

  • Elafibranor resolves NASH without fibrosis worsening

    • Authors: SA Ratziu, V Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, …

    • Year: 2016

    • Citations: 1,217

  • Sofosbuvir and ribavirin in HCV genotypes 2 and 3

    • Authors: ER Zeuzem, S Dusheiko, GM Salupere, R Mangia, A Flisiak, RH Hyland, …

    • Year: 2014

    • Citations: 1,048

  • A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

    • Authors: Not listed

    • Year: 2024

    • Citations: 983

  • Gene expression of TNF-α and TNF receptors in NASH patients

    • Authors: J Crespo, A Cayón, P Fernández‐Gil, M Hernández‐Guerra, M Mayorga, …

    • Year: 2001

    • Citations: 971

  • Advancing the global public health agenda for NAFLD: Consensus statement

    • Authors: JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, …

    • Year: 2022

    • Citations: 683

Vasileios Alexandros Karakousis | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Vasileios Alexandros Karakousis | Medicine and Dentistry | Best Researcher Award

Surgery at Aristotle University of Thessaloniki, Greece

Dr. Vasileios Alexandros Karakousis is a multidisciplinary medical professional with dual degrees in Medicine (MD) and Pharmacy (PharmD), complemented by a Master’s in Clinical and Industrial Pharmacology. He is currently a PhD researcher in Plastic Surgery at the Aristotle University of Thessaloniki and teaches in the postgraduate MSc program in Colorectal Surgery at the University of Thessaly. His research portfolio includes over a dozen peer-reviewed publications in high-impact journals, covering areas such as oncology, immunotherapy, diagnostic imaging, and surgical outcomes. He has also presented at major international conferences across Europe. With clinical training in top hospitals in Greece and France, and fluency in English and French, Dr. Karakousis brings a global perspective to his work. His recent research momentum, coupled with academic and teaching contributions, positions him as a promising early-career researcher making impactful strides in medical science and healthcare.

Professional Profile 

Scopus Profile
ORCID Profile 

Education

Dr. Vasileios Alexandros Karakousis holds an impressive academic background with dual professional degrees. He earned his Doctor of Pharmacy (PharmD) in 2010 and his Doctor of Medicine (MD) in 2017 from the Aristotle University of Thessaloniki (AUTH). He further completed a Master of Science (MSc) in Clinical and Industrial Pharmacology, with a focus on Clinical Toxicology, also from AUTH. Currently, he is pursuing a PhD in Plastic Surgery at Papageorgiou General Hospital, under AUTH’s School of Medicine. His education also includes a European academic exchange through the Erasmus+ Program at Université de Paris. He holds both medical and pharmaceutical licenses from relevant Greek professional bodies. Dr. Karakousis is also multilingual, with certifications in English (C2, University of Michigan) and French (B2, DELF), which enhance his ability to collaborate internationally. His continuous academic development reflects a strong commitment to both scientific inquiry and clinical excellence.

Professional Experience

Dr. Karakousis has cultivated a dynamic professional career across medical, pharmaceutical, and academic domains. He currently teaches in the postgraduate MSc program in Colorectal Surgery at the University of Thessaly, where he contributes to the academic development of future surgeons. His clinical experience spans several prestigious institutions, including AHEPA University Hospital, Ippokrateio Hospital, and hospitals in Paris through externships at Hôpital Saint-Louis and Hôpital Paris Saint-Joseph. His earlier work includes service as a pharmacist in community pharmacies and military medical service at Greek military hospitals. He has also completed a surgical internship and practical training in both hospital and community pharmacy settings. This breadth of experience has shaped him into a well-rounded clinician and academic, capable of bridging pharmaceutical knowledge with surgical and medical practice. His active engagement in multiple clinical environments enhances his ability to apply research insights directly into patient care.

Research Interest

Dr. Karakousis has a broad and evolving set of research interests focused primarily on oncology, surgery, immunology, pharmacology, and diagnostic imaging. His recent research includes systematic reviews, meta-analyses, and case studies in gastrointestinal stromal tumors, medullary thyroid carcinoma, and metastatic colorectal cancer, emphasizing clinical relevance and evidence-based care. He has shown particular interest in cancer immunotherapy, mRNA vaccines, and tumor microenvironment modulation, indicating a forward-looking approach to precision medicine. His work on metaplastic and neuroendocrine breast cancers, as well as rare tumor types, reflects a commitment to addressing under-researched clinical challenges. Additionally, his contributions to diagnostic methodology, such as PET-CT and MRI-endosonography, highlight a keen interest in enhancing preoperative assessment and surgical planning. His multidisciplinary background enables him to pursue translational research that connects pharmacological principles with surgical outcomes and immunological mechanisms, making his academic pursuits both innovative and clinically grounded.

Award and Honor

Dr. Vasileios Alexandros Karakousis has earned recognition through multiple academic and professional achievements, although formal awards are not extensively detailed in the available record. His selection as a presenter at high-level international conferences—including the Joint EWMA-GNEAUPP 2025 Conference in Spain, the 11th Conference of ESES in Turkey, and the 16th Greek-Cypriot Surgical Congress in Cyprus—reflects peer acknowledgment of the quality and significance of his research. He was also a featured presenter at the Scientific Conference of Greek Medical Students, demonstrating early engagement with academic excellence. His role as a lecturer in a postgraduate surgical program further indicates institutional recognition of his expertise. Though not explicitly listed, his numerous peer-reviewed publications in high-impact journals and international collaborations suggest growing influence and respect in the medical research community. These achievements collectively support his eligibility for further awards, including the Best Researcher Award nomination.

Conclusion

Dr. Vasileios Alexandros Karakousis exemplifies the qualities of a promising, multidisciplinary medical researcher. With a robust academic foundation in both medicine and pharmacy, he combines clinical expertise with scientific rigor. His professional journey includes hands-on roles in pharmacy, surgery, teaching, and international externships, highlighting his versatility and dedication to improving healthcare. His recent surge in impactful research—covering oncology, diagnostics, pharmacology, and immunotherapy—demonstrates a forward-thinking, evidence-based approach that resonates with current global healthcare priorities. As a multilingual academic with international experience, he is well-positioned for collaboration and leadership in cross-border research initiatives. While his career is still in a growth phase, his academic trajectory, research contributions, and teaching involvement underscore his potential to make lasting contributions to medical science. Based on his achievements and promise, Dr. Karakousis is a compelling candidate for recognition such as the World Top Scientists Best Researcher Award.

Publications Top Notes

  • Multifocal Gastrointestinal Stromal Tumors (GISTs) of the Small Intestine in Patients with Neurofibromatosis Type 1 (NF-1): Meta‑Analysis and Systematic Review of the Literature

    • Authors: Stylianos Mantalovas; Vasileios Alexandros Karakousis; Christina Sevva; Panagiota Roulia; Stavros Savvakis; Georgios Anthimidis; Konstantinos Papadopoulos; Vasiliki Magra; Nikolaos Varsamis; Christoforos S. Kosmidis; et al.

    • Year: 2025

  • The Efficacy of Positron Emission Tomography/Computed Tomography Scan (PET CT) in the Diagnosis of Local Recurrence and Metastases in Surgical Patients with Medullary Thyroid Carcinoma: A Systematic Review and Meta‑Analysis of the Last 5 Years (2020–2024)

    • Authors: Konstantinos Papadopoulos; Ioannis Iakovou; Stylianos Mantalovas; Christoforos S. Kosmidis; Stiliani Laskou; Vasileios Alexandros Karakousis; Christina Sevva; Marios Dagher; Panagiota Roulia; Ismini Kountouri; et al.

    • Year: 2024

  • Streamline Flow of the Portal Vein Affects the Distribution of Colorectal Cancer Metastases: Clinical Reality or Just a Belief? A Systematic Review and Meta‑Analysis

    • Authors: Stavros Savvakis; Vasileios I. Lagopoulos; Stylianos Mantalovas; Eleni Paschou; Periklis Kopsidas; Christina Sevva; Alexandros Vasileios Karakousis; Eleni Gigi; Isaak Kesisoglou

    • Year: 2024

  • A 78‑Year‑Old Man with Elastofibroma Dorsi Presenting as a Left Subscapular Mass

    • Authors: Christoforos S. Kosmidis; Konstantinos Vlassopoulos; Chrysi Maria Mystakidou; Vasiliki Theodorou; Alexandros Vasileios Karakousis; Nikolaos Iason Katsios; Fedra Louloudopoulou; Anna Andreadi; Paris Pentousis; Stylianos Mantalovas; et al.

    • Year: 2024

  • Neuroendocrine Breast Carcinoma: Interesting Images of an Underdiagnosed Entity

    • Authors: Christoforos Kosmidis; Kassiani Boulogeorgou; Panagiota ___; Marios Dagher; Georgios Anthimidis; Georgios Petrakis; Charilaos Koulouris; Stylianos Mantalovas; Styliani Laskou; Vasiliki Magra; et al.

    • Year: 2024

  • Immune‑Specific and Tumor‑Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy

    • Authors: Theodora Katopodi; Savvas Petanidis; Eirini Grigoriadou; Doxakis Anestakis; Charalampos Charalampidis; Ioanna P. Chatziprodromidou; George Floros; Panagiotis Eskitzis; Paul Zarogoulidis; Charilaos Koulouris; et al. (includes V. A. Karakousis)

    • Year: 2024

  • Metaplastic Breast Carcinoma – A Rare Subtype of Breast Cancer that Poses a Challenge to Treatment: 2 Case Reports and Review of the Literature

    • Authors: Vasiliki Magra; Sofia Baka; Eleni Georgakoudi; Vasiliki Theodorou; Chrysi Maria Mystakidou; Evanthia Papadopoulou; Alexandros Karakousis; Petrina Miltiadous; Georgios Anthimidis; Christoforos Kosmidis

    • Year: 2024

  • Tumor Cell Metabolic Reprogramming and Hypoxic Immunosuppression: Driving Carcinogenesis to Metastatic Colonization

    • Authors: Theodora Katopodi; Savvas Petanidis; Doxakis Anestakis; Charalampos Charalampidis; Ioanna Chatziprodromidou; George Floros; Panagiotis Eskitzis; Paul Zarogoulidis; Charilaos Koulouris; Christina Sevva; et al.

    • Year: 2024

  • Acute Gangrenous Appendicitis in a 70‑Year‑Old Patient with Multiple Myeloma

    • Authors: (Not fully listed); Vasileios Alexandros Karakousis included.

    • Year: 2024

  • Preoperative Assessment of Perianal Fistulas with Combined Magnetic Resonance and Three-Dimensional Endoanal Ultrasound: A Prospective Study

    • Authors: Nikolaos Varsamis; Christoforos Kosmidis; Grigorios Chatzimavroudis; Fani Apostolidou Kiouti; Christoforos Efthymiadis; Vasilis Lalas; Chrysi Maria Mystakidou; Christina Sevva; Konstantinos Papadopoulos; Georgios Anthimidis; et al.

    • Year: 2023

  • Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration

    • Authors: Vasileios Alexandros Karakousis; Danai Liouliou; Aikaterini Loula; Nikoleta Kagianni; Eva‑Maria Dietrich; Soultana Meditskou; Antonia Sioga; Theodora Papamitsou

    • Year: 2020

  • Potential Drug–Drug Interactions in Prescriptions Dispensed in Community Pharmacies in Greece

    • Authors: Anna Chatsisvili; Ioakeim Sapounidis; Georgia Pavlidou; Eudoxia Zoumpouridou; Vasileios‑Alexandros Karakousis; Marios Spanakis; Lefteris Teperikidis; Ioannis Niopas

    • Year: 2010

Gebeyehu Bulcha | Health Professions | Best Researcher Award

Published on by World Top Scientists

Dr. Gebeyehu Bulcha | Health Professions | Best Researcher Award

Researcher at Jimma University, Ethiopia

Dr. Gebeyehu Bulcha Duguma is a seasoned public health expert and researcher with over 16 years of experience in maternal, newborn, and child health (MNCH), epidemiology, and health communication. He holds a Master of Public Health in Epidemiology and is currently pursuing a PhD in Health Communication and Health Behavior. Dr. Bulcha has contributed to more than 25 peer-reviewed publications, with a focus on digital health innovations, behavior change communication, and health system strengthening. His work integrates practical field experience with academic research, having served in various roles including PHEOC Coordinator, RMNCH Expert, and consultant for organizations like KOICA, KOFIH, and IMCHA. He is also recognized for mentoring young epidemiologists and developing mobile health tools such as the Ulfamijuu messaging platform. With a multidisciplinary background and a commitment to evidence-based interventions, Dr. Bulcha stands out as a leader driving impactful public health research and innovation in Ethiopia and beyond.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile

Education

Dr. Gebeyehu Bulcha Duguma has pursued a multidisciplinary academic journey grounded in public health and social sciences. He holds a Bachelor of Science in Environmental Health from Haramaya University and a Bachelor of Arts in Sociology and Social Work from Jimma University. He further advanced his expertise by earning a Master of Public Health in Epidemiology from Jimma University, where he developed a strong foundation in disease surveillance and health data analytics. Currently, Dr. Bulcha is a PhD candidate in Health Communication and Health Behavior at Jimma University, where his research focuses on innovative communication strategies to improve maternal and child health outcomes. His academic pursuits are deeply aligned with his professional commitments, equipping him with the theoretical and methodological tools to address complex public health challenges. His educational background reflects a unique blend of technical, behavioral, and communication expertise, making him well-suited for interdisciplinary health research and interventions.

Professional Experience

With over 16 years of progressive experience, Dr. Gebeyehu Bulcha has held a range of pivotal roles in public health. He has served as a Public Health Emergency Operations Center (PHEOC) Coordinator, leading epidemic surveillance and response, while mentoring Field Epidemiology Training Program (FETP) residents. From 2016 to 2019, he worked as an RMNCH Expert, coordinating maternal-child health programs, WASH interventions, and behavioral change communication initiatives. Earlier roles include HIV/AIDS Coordinator, Malaria Coordinator, and Maternal & Child Health Expert, all contributing to his rich operational background. He has also worked with international partners as a consultant or project management member in organizations like KOICA, KOFIH, ABH, and IMCHA. Dr. Bulcha has managed several large-scale public health projects and has delivered capacity-building trainings, campaign coordination, and strategic planning, demonstrating leadership across policy, research, and community-based implementation. His career showcases a deep integration of practice, mentorship, and policy-level influence.

Research Interest

Dr. Bulcha’s research interests center on maternal, newborn, and child health (MNCH), health communication, mobile health (mHealth) technologies, and epidemiology. He is particularly passionate about leveraging digital platforms to improve health behaviors and service utilization, as evidenced by his recent work on developing the Ulfamijuu mobile messaging software. His research also explores health systems strengthening, community engagement, and the use of spatial analysis and mixed-methods studies to understand public health barriers and enablers. He has contributed to more than 25 publications in peer-reviewed journals, with topics ranging from mobile messaging interventions to health information systems and social determinants of health. His research frequently adopts a user-centered design approach, ensuring that interventions are practical and culturally appropriate. Dr. Bulcha’s focus on integrating technology with behavioral science reflects a forward-thinking and impactful research agenda, tailored to address public health challenges in low-resource settings like Ethiopia.

Award and Honor

While specific formal awards are not detailed in the available documentation, Dr. Gebeyehu Bulcha Duguma’s recognition stems from his extensive contributions to high-impact public health research and programs. He has served as Principal Investigator (PI) and Co-PI on numerous funded projects supported by international organizations such as KOFIH, KOICA, and IMCHA, which in itself reflects trust in his leadership and research capabilities. His peer-reviewed publications in prestigious journals such as BMJ Open, BMC Public Health, and JMIR Research Protocols highlight the academic community’s acknowledgment of his work. Additionally, his continuous invitations to contribute as a consultant, trainer, and lead researcher on national and international projects stand as informal honors affirming his expertise. His selection to present at the 35th EPHA Annual Conference and his leadership in developing mobile health technologies further signify his status as an innovator and leader in Ethiopian public health research.

Conclusion

Dr. Gebeyehu Bulcha Duguma exemplifies the qualities of a transformative public health leader and researcher. With a multidisciplinary educational background, hands-on experience across multiple domains of public health, and a strong research portfolio, he has made significant contributions to improving health outcomes in Ethiopia. His work on mobile health interventions, capacity building, and community health systems bridges the gap between research and practical implementation. He stands out for his ability to integrate epidemiological rigor with innovative communication strategies, enhancing the reach and effectiveness of public health programs. Through numerous collaborations with international organizations, he has demonstrated leadership, innovation, and sustained impact in the field. Dr. Bulcha is a strong candidate for the Best Researcher Award, not only for the volume and quality of his research but also for its relevance, scalability, and alignment with global health priorities. His career reflects a commitment to evidence-based practice and a vision for health equity and innovation.

Publications Top Notes

  • Title: A quality assessment of Health Management Information System (HMIS) data for maternal and child health in Jimma Zone, Ethiopia
    Authors: M Ouedraogo, J Kurji, L Abebe, R Labonté, S Morankar, KH Bedru, G Bulcha, et al.
    Year: 2019
    Citations: 88

  • Title: Factors associated with maternity waiting home use among women in Jimma Zone, Ethiopia: a multilevel cross-sectional analysis
    Authors: J Kurji, LA Gebretsadik, MA Wordofa, M Sudhakar, Y Asefa, G Kiros, G Bulcha, et al.
    Year: 2019
    Citations: 53

  • Title: Effectiveness of upgraded maternity waiting homes and local leader training on improving institutional births: a cluster-randomized controlled trial in Jimma, Ethiopia
    Authors: J Kurji, LA Gebretsadik, MA Wordofa, S Morankar, KH Bedru, G Bulcha, et al.
    Year: 2020
    Citations: 26

  • Title: Utilization of key preventive measures for pregnancy complications and malaria among women in Jimma Zone, Ethiopia
    Authors: M Ouedraogo, J Kurji, L Abebe, R Labonté, S Morankar, KH Bedru, G Bulcha, et al.
    Year: 2019
    Citations: 14

  • Title: Uncovering spatial variation in maternal healthcare service use at subnational level in Jimma Zone, Ethiopia
    Authors: J Kurji, B Talbot, G Bulcha, KH Bedru, S Morankar, LA Gebretsadik, et al.
    Year: 2020
    Citations: 12

  • Title: Maternal social support and health facility delivery in Southwest Ethiopia
    Authors: A Mamo, M Abera, L Abebe, N Bergen, S Asfaw, G Bulcha, Y Asefa, et al.
    Year: 2022
    Citations: 8

  • Title: Effectiveness of a Mobile Phone Messaging–Based Message Framing Intervention for Improving Maternal Health Service Uptake and Newborn Care Practice in Rural Jimma Zone
    Authors: G Bulcha, HG Abdissa, J Noll, DA Sori, ZB Koricha
    Year: 2024
    Citations: 4

  • Title: Community’s knowledge, perceptions and preventive practices on Onchocerciasis in Jimma zone, Ethiopia, formative mixed study
    Authors: D Abdissa, Y Kebede, M Sudhakar, G Abraham, G Bulcha, T Shiferaw, et al.
    Year: 2024
    Citations: 4

  • Title: Prevalence and Predictors of Contraceptive Use Among Women of Premenopausal Period in Ethiopia: A Retrospective Cross-Sectional Data Analysis
    Authors: D Geleta, A Kebede, G Bulcha, H Usman, K Hajibediru, S Kebede, et al.
    Year: 2021
    Citations: 4

  • Title: Spatial variability in factors influencing maternal health service use in Jimma Zone, Ethiopia: a geographically-weighted regression analysis
    Authors: J Kurji, C Thickstun, G Bulcha, M Taljaard, Z Li, MA Kulkarni
    Year: 2021
    Citations: 3

  • Title: Effectiveness of Integrated Social and Behavior Change Communication Interventions in Mass Drug Administration Campaigns in Enhancing Knowledge, Perceptions, and Preventive Practices
    Authors: D Abdissa, Y Kebede, S Morankar, G Abraham, G Bulcha, T Shiferaw, et al.
    Year: 2024
    Citations: 2

  • Title: Maternal health service utilization in the Jimma Zone, Ethiopia: results from a baseline study for mobile phone messaging interventions
    Authors: G Bulcha, H Gutema, D Amenu, Z Birhanu
    Year: 2024
    Citations: 2

  • Title: Exploring religious leaders’ experiences and challenges on childbirth at health institutions. A qualitative study
    Authors: L Abebe, Z Birhanu, N Bergen, G Bulcha, K Haji, M Kulkarni, J Kurji, et al.
    Year: 2022
    Citations: 2

  • Title: Barriers to use of institutional childbirth services: A qualitative study in the rural Jimma Zone, Ethiopia
    Authors: LA Gebretsadik, F Lakew, A Mamo, M Abera, KH Bediru, G Bulcha, et al.
    Year: 2024
    Citations: 1

  • Title: Maternal Social Support and Determinants of Health Facility Delivery in Rural Ethiopia
    Authors: A Mamo, M Abera, L Abebe, N Bergen, S Asfaw, G Bulcha, Y Asefa, et al.
    Year: 2021
    Citations: 1